Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce V Taylor

Showing results (131-140 of 194) with videos related to

Pageof 20
Sort By:
Journal of Neuroimmunology|August 25, 2022
Plexus MRI helps distinguish the immune-mediated neuropathies MADSAM and MMNGrayson Beecher, Benjamin M Howe, Shahar Shelly, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 27, 2023
HLA-DRB1*15:01 and the <i>MERTK</i> Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MSMichele D Binder, Eze C Nwoke, Ellen Morwitch, et al.
Multiple Sclerosis and Related Disorders|August 8, 2025
Identifying distinct symptom profiles in people living with MS: Implications for quality of life and clinical careLaura L Laslett, C Leigh Blizzard, Valery Fuh-Ngwa, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 2, 2023
Genetically determined serum serine level has a novel causal effect on multiple sclerosis risk and predicts disability progressionXin Lin, Yuanhao Yang, Valery Fuh-Ngwa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 24, 2018
Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosisHasnat Ahmad, Ingrid van der Mei, Bruce V Taylor, et al.
Scientific Reports|July 18, 2023
The association between disability progression, relapses, and treatment in early relapse onset MS: an observational, multi-centre, longitudinal cohort studyValery Fuh-Ngwa, Jac C Charlesworth, Yuan Zhou, et al.
Multiple Sclerosis and Related Disorders|February 8, 2018
The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adultsJennifer S Graves, Lisa F Barcellos, Steve Simpson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 13, 2022
Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelinationAmin Zarghami, Ingrid van der Mei, Mohammad Akhtar Hussain, et al.
Frontiers in Immunology|June 16, 2023
Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosisAlexandre Xavier, Maria Pia Campagna, Vicki E Maltby, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 26, 2017
Genetic variation in the gene <i>LRP2</i> increases relapse risk in multiple sclerosisYuan Zhou, Jennifer S Graves, Steve Simpson, et al.
Pageof 20

Showing results (131-140 of 194) with videos related to

Sort By:
Pageof 20
Journal of Neuroimmunology|August 25, 2022
Plexus MRI helps distinguish the immune-mediated neuropathies MADSAM and MMNGrayson Beecher, Benjamin M Howe, Shahar Shelly, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 27, 2023
HLA-DRB1*15:01 and the <i>MERTK</i> Gene Interact to Selectively Influence the Profile of MERTK-Expressing Monocytes in Both Health and MSMichele D Binder, Eze C Nwoke, Ellen Morwitch, et al.
Multiple Sclerosis and Related Disorders|August 8, 2025
Identifying distinct symptom profiles in people living with MS: Implications for quality of life and clinical careLaura L Laslett, C Leigh Blizzard, Valery Fuh-Ngwa, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 2, 2023
Genetically determined serum serine level has a novel causal effect on multiple sclerosis risk and predicts disability progressionXin Lin, Yuanhao Yang, Valery Fuh-Ngwa, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 24, 2018
Estimation of annual probabilities of changing disability levels in Australians with relapsing-remitting multiple sclerosisHasnat Ahmad, Ingrid van der Mei, Bruce V Taylor, et al.
Scientific Reports|July 18, 2023
The association between disability progression, relapses, and treatment in early relapse onset MS: an observational, multi-centre, longitudinal cohort studyValery Fuh-Ngwa, Jac C Charlesworth, Yuan Zhou, et al.
Multiple Sclerosis and Related Disorders|February 8, 2018
The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adultsJennifer S Graves, Lisa F Barcellos, Steve Simpson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 13, 2022
Long-term trajectories of employment status, workhours and disability support pension status, after a first episode of CNS demyelinationAmin Zarghami, Ingrid van der Mei, Mohammad Akhtar Hussain, et al.
Frontiers in Immunology|June 16, 2023
Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosisAlexandre Xavier, Maria Pia Campagna, Vicki E Maltby, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 26, 2017
Genetic variation in the gene <i>LRP2</i> increases relapse risk in multiple sclerosisYuan Zhou, Jennifer S Graves, Steve Simpson, et al.
Pageof 20